24.02.2013 Views

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Boulikas</strong>: An overview on gene <strong>therapy</strong><br />

Figure 1. Role of E1A and E1B19-kDa proteins of adenovirus in apoptosis.<br />

penetration of the adenoviral particles by acid-catalyzed<br />

rupture of the endosomal membrane involving the penton<br />

protein and the integrins and allowing escape to the<br />

cytoplasmic compartment; a decrease in endosome pH<br />

during internalization expose hydrophobic domains of<br />

these adenoviral capsid proteins which permits these<br />

proteins to insert into the vesicle membrane in a fashion<br />

that ultimately disrupts its integrity (Seth et al, 1984). At<br />

the final step the adenoviral particle is attached to the<br />

cytoplasmic side of pore complexes and the DNA is<br />

released to the interior of pore annuli entering the<br />

nucleoplasm.<br />

These highly ordered processes are accompanied by<br />

losses or protease degradation of specific proteins on the<br />

viral particles; the fibers and some of the penton base<br />

complexes on the adenovirus surface are already lost<br />

during the process of endocytosis; a viral protease,<br />

L3/p23, located inside the capsid at 10 copies per virion,<br />

plays a key role in the stepwise dismantling and in the<br />

weakening of the capsid structure culminating with the<br />

release of the adenovirus DNA by degrading of the viral<br />

capsid protein VI (Greber et al, 1996). The mechanism of<br />

disruption of endosomes by the adenoviral particles has<br />

been exploited to augment efficiency of transfection with<br />

transferrin-polylysine-DNA complexes (see fusogenic<br />

peptides and Curiel et al, 1991; Cotten et al, 1992; Wagner<br />

et al, 1992b; Cristiano et al, 1993; Morishita et al, 1993;<br />

Harries et al, 1993; Curiel, 1994).<br />

To overcome one of the major limitations to the<br />

clinical utility of adenoviruses which is the low efficiency<br />

of gene transfer achieved in vivo, Arcasoy et al (1997)<br />

found that the presence of the polycations polybrene,<br />

protamine, DEAE-dextran, and poly-L-lysine significantly<br />

increased the transfection efficiency in cell culture using<br />

the lacZ gene; because the polyanion heparin did not<br />

10<br />

significantly alter gene transfer efficiency, but completely<br />

abrogated the effects of polycations it supports the idea<br />

that the negative charges presented by membrane<br />

glycoproteins reduce the efficiency of adenovirusmediated<br />

gene transfer, an obstacle that can be overcome<br />

by polycations.<br />

D. Advantages and drawbacks of<br />

adenoviral vectors in gene delivery<br />

Adenoviruses possess a linear double-stranded genome<br />

which can be manipulated to accommodate up to 7.5 kb of<br />

DNA. Adenoviruses have the advantage of being able to<br />

infect nondividing cells. Other advantages are the rarity of<br />

recombination events between adenoviral vectors and the<br />

host chromosomes, the absence of induction of human<br />

malignancies by adenoviruses, and the relative safety of<br />

their use as vaccines (e.g. Ballay et al, 1985; Haj-Ahmad<br />

and Graham, 1986). For safety, replication-deficient,<br />

infectious adenoviruses are being used in somatic gene<br />

transfer; for example deletion in a portion of the E3 region<br />

of the virus permits encapsidation whereas deletion of a<br />

portion of the E1A coding sequence impairs viral<br />

replication (Gilardi et al, 1990; Rosenfeld et al, 1991).<br />

E. Deletion of adenoviral DNA sequences<br />

for gene delivery<br />

First generation recombinant adenoviruses were<br />

rendered defective by deletion of sequences spanning the<br />

E1A and E1B genes; these adenoviruses expressed low<br />

levels of early and late viral genes responsible for<br />

activating destructive cellular immune responses. Further<br />

deletion of other essential genes and growth in new<br />

packaging cell lines or incorporation of temperature

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!